DekaBank Deutsche Girozentrale
KYNB icon

DekaBank Deutsche Girozentrale’s Kyntra Bio KYNB Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,230
Closed -$570K – 1275
2023
Q1 		$570K Hold
1,230
– – ﹤0.01% 991
2022
Q4 		$478K Hold
1,230
– – ﹤0.01% 1047
2022
Q3 		$402K Hold
1,230
– – ﹤0.01% 1085
2022
Q2 		$331K Hold
1,230
– – ﹤0.01% 1097
2022
Q1 		$373K Buy
1,230
+112
+10% +$39K ﹤0.01% 1112
2021
Q4 		$397K Buy
1,118
+40
+4% +$12.5K ﹤0.01% 1150
2021
Q3 		$276K Hold
1,078
– – ﹤0.01% 1149
2021
Q2 		$721K Hold
1,078
– – ﹤0.01% 982
2021
Q1 		$837K Hold
1,078
– – ﹤0.01% 938
2020
Q4 		$1.02M Sell
1,078
-52
-5% -$54.7K ﹤0.01% 867
2020
Q3 		$1.16M Buy
+1,130
New +$1.22M 0.01% 717
2019
Q4 		– Sell
-1,170
Closed -$1.11M – 1165
2019
Q3 		$1.11M Sell
1,170
-1,242
-51% -$1.36M 0.01% 645
2019
Q2 		$2.69M Buy
2,412
+1,086
+82% +$1.19M 0.01% 560
2019
Q1 		$2.02M Buy
1,326
+240
+22% +$325K 0.01% 607
2018
Q4 		$1.19M Sell
1,086
-240
-18% -$270K 0.01% 639
2018
Q3 		$2.02M Sell
1,326
-34
-3% -$52.4K 0.01% 620
2018
Q2 		$2.1M Hold
1,360
– – 0.01% 575
2018
Q1 		$1.57M Sell
1,360
-468
-26% -$616K 0.01% 611
2017
Q4 		$1.86M Hold
1,828
– – 0.01% 564
2017
Q3 		$1.86M Hold
1,828
– – 0.01% 569
2017
Q2 		$1.44M Hold
1,828
– – 0.01% 616
2017
Q1 		$1.13M Buy
+1,828
New +$1.11M 0.01% 596
2016
Q3 		– Sell
-1,312
Closed -$538K – 980
2016
Q2 		$538K Buy
1,312
+92
+8% +$42.1K 0.01% 672
2016
Q1 		$629K Buy
+1,220
New +$608K 0.01% 614

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DekaBank Deutsche Girozentrale's KYNB Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 1,230 shares — an estimated $570K sold.

DekaBank Deutsche Girozentrale first reported a position in KYNB in Q1 2016 and held it in 24 quarters. The position peaked at $2.69M in Q2 2019. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • DekaBank Deutsche Girozentrale reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 1,230 Kyntra Bio shares in Q2 2023, an estimated $570K.
  • DekaBank Deutsche Girozentrale first reported a position in Kyntra Bio in Q1 2016 and held it in 24 quarters.
  • DekaBank Deutsche Girozentrale's Kyntra Bio position peaked at $2.69M in Q2 2019.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.